Advanced Prostate Cancer – Basis of Androgen Deprivation Therapy

This course series Advanced Prostate Cancer gives clinicians a complete view on clinical aspects, diagnosis and treatments of prostate cancer. This course series contains five courses, each of them addresses an important topic in diagnosis, treatment, and management of prostate cancer. Each course is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) for 1 to 3 European CME credits (ECMEC). The five courses are:

Course 1: Basis of ADT
Course 2: Non-Metastatic Hormone-Sensitive PCa (published in Mar 2022)
Course 3: Metastatic Hormone-Sensitive PCa (published in June 2020)
Course 4: Non-Metastatic Castration-Resistant PCa (published in November 2020)
Course 5: Metastatic Castration-Resistant PCa (published in Jan 2021 )

This course Basis of Androgen Deprivation Therapy is the first part of the course series.

This course is supported by an independent educational grant from Janssen, the Pharmaceutical Companies of Johnson & Johnson.

Learning Objectives

This series of five e-courses aims to provide HCPs with a complete view of the management of Advanced Prostate Cancer. Users of this training are expected to progress their knowledge in the clinical aspects and management of prostate cancer. Specific learning objectives are as follows:

• Definition of Hormone-sensitive nmPCa / nmPCa / MPCa / CRPC and classification
• Information about diagnostic tools, how to combine them and the value of their results
• Information on prognosis factors, predictive factors and patient stratification
• Information about treatment options, how to combine them, their differences and side-effects, when to progress to the next treatment stage, and how to evaluate these
• Information on sound clinical decision making for patients with nmPCa, MPCa, Metastatic CRPC, and nmCRPC
• Evaluation of learners' knowledge about treatment of nmPCa, MPCa, Metastatic CRPC, and nmCRPC and their ability to apply this knowledge in devising care pathways for patients

chapters

Chapter 1: Androgen Bio-synthesis
Chapter 2: Androgen Deprivation Therapy (ADT)
Chapter 3: Adverse Events and Side Effects

At a glance

• Last update: May 2021
• Publication date: March 2020
• Available languages: English
• Topic: Prostate cancer
• Duration: 90 minutes per course approximately
• CME: 1 European CME credits (ECMEC)

Contributing Authors

Prof. dr. N. Mottet (Chair of the EAU PCa Guidelines Panel)